Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 49 No. 2 Articles 2019 Tags: Alessandra Gasparini, antipsychotics, Camilla Callegari, early treatment, Giorgia Lorenzoli, Giulia Lucca, Ivano Caselli, long-acting injections, Marta Ielmini, Nicola Poloni, recovery, schizophrenia

Description

Description

Original Research

Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting

By Nicola Poloni, Marta Ielmini, Ivano Caselli, Giulia Lucca, Alessandra Gasparini, Giorgia Lorenzoli, Camilla Callegari

Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting

Description

Original Research

Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia

Jane P. Gagliardi, MD: Treatment of Thyrotoxicosis-Induced Psychosis

Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications

Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting

Description

Original Research

Related products

Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series

Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia

Jane P. Gagliardi, MD: Treatment of Thyrotoxicosis-Induced Psychosis

Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications